Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biocomputational Screening of Natural Compounds against Acetylcholinesterase
Syed Sayeed Ahmad, Mohd. Babu Khan, Khurshid Ahmad, et al.
Molecules (2021) Vol. 26, Iss. 9, pp. 2641-2641
Open Access | Times Cited: 16

Showing 16 citing articles:

Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer’s Disease
Shanshan Wang, Xianbo Kong, Zhangjing Chen, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4175-4175
Open Access | Times Cited: 23
Dipeptidyl peptidase-4 inhibitory potentials of Glycyrrhiza uralensis and its bioactive compounds licochalcone A and licochalcone B: An in silico and in vitro study
Sibhghatulla Shaikh, Shahid Ali, Jeong Ho Lim, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 22
Advances of computer-aided drug design (CADD) in the development of anti-Azheimer’s-disease drugs
Yuzhen Niu, Ping Lin
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103665-103665
Closed Access | Times Cited: 15
Inhibitory Effects of Alkaloids Against Enzymes Linked to Neurodegenerative Diseases
İlkay Erdoğan Orhan, Fatma Sezer Şenol
Springer eBooks (2025), pp. 1-21
Closed Access
The pharmacokinetics profiles, pharmacological properties, and toxicological risks of dehydroevodiamine: A review
Shubin Fu, Liying Liao, Yi Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Proposing novel natural compounds against Alzheimer’s disease targeting acetylcholinesterase
Münteha Girgin, Sevim Işık, Nigar Kantarci-Carsibasi
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0284994-e0284994
Open Access | Times Cited: 8
Computational Identification of Dithymoquinone as a Potential Inhibitor of Myostatin and Regulator of Muscle Mass
Syed Sayeed Ahmad, Khurshid Ahmad, Eun Ju Lee, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5407-5407
Open Access | Times Cited: 19
Therapeutic Effects of the major alkaloid constituents of Evodia rutaecarpa in Alzheimer's disease
Qingyu Cao, Peiliang Dong, Hua Han
Psychogeriatrics (2024) Vol. 24, Iss. 2, pp. 443-457
Closed Access | Times Cited: 1
Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy
Sibhghatulla Shaikh, Khurshid Ahmad, Syed Sayeed Ahmad, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 10
Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
Sibhghatulla Shaikh, Shahid Ali, Jeong Ho Lim, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2152-2152
Open Access | Times Cited: 2
A theoretical screening of phytochemical constituents from Millettia Brandisiana as inhibitors against acetylcholinesterase
Hue Van Nguyen, Nguyen Xuan Ha, Duy Phuong Nguyen, et al.
Physical Chemistry Chemical Physics (2024) Vol. 26, Iss. 23, pp. 16898-16909
Closed Access
Enzyme ChE, cholinergic therapy and molecular docking: Significant considerations and future perspectives
Snežana M Jovičić
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access
Investigating the Potency of Erythrina‒Derived Flavonoids as Cholinesterase Inhibitors and Free Radical Scavengers Through in silico Approach: Implications for Alzheimer’s Disease Therapy
Abd. Wahid Rizaldi Akili, Nisrina Azizah Thurfah, Ari Hardianto, et al.
Advances and Applications in Bioinformatics and Chemistry (2024) Vol. Volume 17, pp. 107-118
Open Access
On the steroids extracted from soft corals against the NS3/4A protease of hepatitis C virus
Duy Phuong Nguyen, Ha Xuan Nguyen, Hue Van Nguyen, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 136, pp. 108936-108936
Closed Access
Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer’s Disease: A Review
Syed Sayeed Ahmad, Kaiser Younis, Philippe Jeandet, et al.
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 7, pp. 610-620
Closed Access | Times Cited: 2
Research Progress in Pharmacological Action of Dehydroevodiamine
Jiangfa Li, Hao Peng, Jiang Yiqi, et al.
(2023)
Open Access
Page 1

Scroll to top